Figure 4. Correlations between TP53BP2 and the
clinicopathological characteristics of patients with PE. (A, B) Pearson’s correlation analysis between TP53BP2 expression and LC3B-II or
p62 in placentas from PE pregnancies and non-PE pregnancies.(C-G) Pearson’s correlation analysis between TP53BP2 expression
and systolic blood pressure (C) , diastolic blood pressure(D) , BMI (E) , gestational age (F) , and
neonatal birth weight (G) in PE pregnancies and non-PE
pregnancies. (H) The cutoff value, sensitivity, and specificity
were established via receiver operating characteristic (ROC) curves to
evaluate the diagnostic value of TP53BP2 in PE pregnancies. The data are
presented as the means ± SDs. **P <0.01.